BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8683989)

  • 1. Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia.
    Pfeilstöcker M; Karlic H; Salamon J; Krömer E; Mühlberger H; Pavlova B; Selim U; Tüchler H; Fritsch G; Kneissl S; Heinz R; Pitterman E; Paukovits MR
    Leukemia; 1996 Jul; 10(7):1117-21. PubMed ID: 8683989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
    Pfeilstöcker M; Karlic H; Paukovits J; Anzenberger G; Louda N; Salamon J; Mühlberger H; Strobl H; Pittermann E; Heinz R
    Leukemia; 1999 Apr; 13(4):590-4. PubMed ID: 10214866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
    Iversen PO; Wiig H
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation.
    Tenailleau S; Corre I; Hermouet S
    Exp Hematol; 1997 Aug; 25(9):927-34. PubMed ID: 9257805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.
    Deguchi Y; Yamanaka Y; Theodossiou C; Najfeld V; Kehrl JH
    Leukemia; 1993 Mar; 7(3):446-51. PubMed ID: 7680402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially therapeutically relevant differences of antisense oligonucleotide uptake in CD34+ hematopoietic stem cells, leukemic blasts and cancer cells from patients.
    Seitz G; Kohler G; Nehmzow M; Lorenz G; Denzlinger C; Müller C; Bader P; Brischwein K; Beck JF
    Anticancer Res; 2002; 22(3):1717-9. PubMed ID: 12168859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
    Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
    Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
    MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
    Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro functional alterations in the hematopoietic system of adult patients with acute lymphoblastic leukemia.
    Martínez-Jaramillo G; Vela-Ojeda J; Sánchez-Valle E; Montesinos JJ; Mayani H
    Leuk Res; 2007 Jan; 31(1):83-9. PubMed ID: 16769114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.
    Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E
    Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
    Rosnet O; Bühring HJ; Marchetto S; Rappold I; Lavagna C; Sainty D; Arnoulet C; Chabannon C; Kanz L; Hannum C; Birnbaum D
    Leukemia; 1996 Feb; 10(2):238-48. PubMed ID: 8637232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.